Mira Moufarrej is presently a Swanson Fellow at The Column Group, a science-driven venture capital firm. She previously developed 3 liquid biopsy tests that measure cell-free RNA (cfRNA) to predict how far
along a pregnancy is and whether a pregnant individual is at risk of preeclampsia and preterm delivery long before traditional diagnostics. This work paves the way for affordable, simple, and reliable tests for
preeclampsia and preterm delivery – risks that no other test can presently diagnose early enough to
allow for meaningful clinical intervention. To enable such discoveries, she has also built a semiautomated
pipeline to process samples, a notoriously tedious task, which to date, has extracted cfRNA
from ~1100 samples in 9 days. For this work, Mira received the 2021 “Cure it!” Lemelson-MIT Student
Prize. Her work has been published in Science and Nature. It has also been highlighted by the New
York Times, MIT Technology Review, CNN and Insider, among others. Mira holds a PhD in
bioengineering and MS in computer science from Stanford University.
Mira Moufarrej is presently a Swanson Fellow at The Column Group, a science-driven venture capital firm. She previously developed 3 liquid biopsy tests that measure cell-free RNA (cfRNA) to predict how far
along a pregnancy is and whether a pregnant individual is at risk of preeclampsia and preterm delivery long before traditional diagnostics. This work paves the way for affordable, simple, and reliable tests for
preeclampsia and preterm delivery – risks that no other test can presently diagnose early enough to
allow for meaningful clinical intervention. To enable such discoveries, she has also built a semiautomated
pipeline to process samples, a notoriously tedious task, which to date, has extracted cfRNA
from ~1100 samples in 9 days. For this work, Mira received the 2021 “Cure it!” Lemelson-MIT Student
Prize. Her work has been published in Science and Nature. It has also been highlighted by the New
York Times, MIT Technology Review, CNN and Insider, among others. Mira holds a PhD in
bioengineering and MS in computer science from Stanford University.
Mira Moufarrej is presently a Swanson Fellow at The Column Group, a science-driven venture capital firm. She previously developed 3 liquid biopsy tests that measure cell-free RNA (cfRNA) to predict how far
along a pregnancy is and whether a pregnant individual is at risk of preeclampsia and preterm delivery long before traditional diagnostics. This work paves the way for affordable, simple, and reliable tests for
preeclampsia and preterm delivery – risks that no other test can presently diagnose early enough to
allow for meaningful clinical intervention. To enable such discoveries, she has also built a semiautomated
pipeline to process samples, a notoriously tedious task, which to date, has extracted cfRNA
from ~1100 samples in 9 days. For this work, Mira received the 2021 “Cure it!” Lemelson-MIT Student
Prize. Her work has been published in Science and Nature. It has also been highlighted by the New
York Times, MIT Technology Review, CNN and Insider, among others. Mira holds a PhD in
bioengineering and MS in computer science from Stanford University.